Go Pro
Puneet Souda

Puneet Souda Analyst Performance

Senior Research Analyst at Leerink Partners

Puneet Souda is a stock analyst at Leerink Partners focused in the medical sector, covering 18 publicly traded companies. Over the past year, Puneet Souda has issued 14 stock ratings, including buy and hold recommendations. While full access to Puneet Souda's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Puneet Souda's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
42 Last 9 Years
Buy Recommendations
90.00% 36 Buy Ratings
Companies Covered
18 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy90.0%36 ratings
Hold10.0%4 ratings
Sell0.0%0 ratings

Out of 40 total stock ratings issued by Puneet Souda at Leerink Partners, the majority (90.0%) have been Buy recommendations, followed by 10.0% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
83.3% of companies on NASDAQ
15 companies
NYSE
16.7% of companies on NYSE
3 companies

Puneet Souda, an analyst at Leerink Partners, currently covers 18 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Medical
15 companies
83.3%
Computer and Technology
1 company
5.6%
Manufacturing
1 company
5.6%
Transportation
1 company
5.6%

Puneet Souda of Leerink Partners specializes in stock coverage within the Medical sector, with additional focus on Computer and Technology and Manufacturing companies.

Coverage Industries

IndustryPercentage
MED - BIOMED/GENE
7 companies
38.9%
MED INSTRUMENTS
4 companies
22.2%
INSTRU - SCIENTFC
1 company
5.6%
LAB ANALYTICAL INSTRUMENTS
1 company
5.6%
TRANS - SERVICES
1 company
5.6%
MED PRODUCTS
1 company
5.6%
MED - DRUGS
1 company
5.6%
SURGICAL & MEDICAL INSTRUMENTS
1 company
5.6%
MEDICAL LABORATORIES
1 company
5.6%

About Puneet Souda

Puneet Souda is a Senior Research Analyst at Leerink Partners covering Life Science Tools and Diagnostics. His research focuses on companies and technologies within the Life Science Tools subsector, the Diagnostics subsector, and selected areas of Pharmaceutical Services. Prior to joining the Firm in 2014, Puneet was a Senior Associate at Citigroup covering Medical Devices. Before joining Wall Street, he spent over a decade in core and basic research labs at UCLA and Purdue University. In this work, he was a customer and collaborator of many Life Science Tools and Diagnostic companies. Puneet has direct experience in the acquisition, management, and utilization of many life sciences technologies for molecular analysis and diagnostics. He has co-authored over 45 peer-reviewed scientific papers and has built an extensive network of colleagues and collaborators among academic lab researchers and Life Science Tools suppliers. He earned an M.B.A. from University of California-San Diego and undertook graduate study in biotechnology and earned a B.A. in Biology from Purdue University.
Follow on LinkedIn

Puneet Souda's Ratings History at Leerink Partners

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Illumina, Inc. stock logo
ILMN
Illumina
7/17/2026Boost Price Target$184.36$210.00Outperform
Twist Bioscience Corporation stock logo
TWST
Twist Bioscience
7/16/2026Set Price Target$92.61$110.00
Bruker Corporation stock logo
BRKR
Bruker
7/7/2026Boost Price Target$58.39$70.00Outperform
Twist Bioscience Corporation stock logo
TWST
Twist Bioscience
5/22/2026Set Price Target$58.83$80.00
ALMR
Alamar Biosciences
5/12/2026Initiated Coverage$23.88$35.00Outperform
Twist Bioscience Corporation stock logo
TWST
Twist Bioscience
5/5/2026Upgrade$56.19$70.00Outperform
NeoGenomics, Inc. stock logo
NEO
NeoGenomics
4/29/2026Upgrade$9.02$25.00Outperform
Guardant Health, Inc. stock logo
GH
Guardant Health
2/20/2026Boost Price Target$103.10$180.00Outperform
Guardant Health, Inc. stock logo
GH
Guardant Health
12/15/2025Boost Price Target$103.72$155.00Outperform
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
10/22/2025Boost Price Target$568.42$580.00Outperform
Hologic, Inc. stock logo
HOLX
Hologic
10/21/2025Boost Price Target$74.04$78.00Market Perform
Guardant Health, Inc. stock logo
GH
Guardant Health
9/25/2025Boost Price Target$61.55$75.00Outperform
CryoPort, Inc. stock logo
CYRX
CryoPort
8/6/2025Upgrade$6.74$16.00Outperform
908 Devices Inc. stock logo
MASS
908 Devices
8/5/2025Upgrade$6.27$12.00Outperform
Quanterix Corporation stock logo
QTRX
Quanterix
4/30/2025Reiterated Rating$6.05$8.00Market Perform